Dr. Mike Chan, Founder, Chairman, & Chief Scientist, European Wellness Biomedical Group
For more than four decades, Prof. Dato’ Sri Dr. Mike Chan has pursued a question most of medicine once dismissed as philosophical: Can aging be treated—not managed, not endured, but actively reversed?
Today, as Founder, Chairman, and Chief Scientist of European Wellness Biomedical Group (EWBG), Prof. Mike Chan stands among the world’s most influential figures in progenitor stem cell therapy, regenerative medicine, and longevity science—a field now rapidly moving from theory to clinical reality. His work spans over 40 medical and research centers worldwide, bridging Europe’s most rigorous biomedical traditions with Asia’s rapidly evolving healthcare ecosystem.
From Cancun to Las Vegas, from Europe to Greater China, Prof. Mike Chan’s presence is defined not by intimate classrooms but by packed halls, international congresses, and audiences numbering in the hundreds and thousands—a scale that reflects both demand and authority.
From Europe’s Laboratories to the World’s Clinics
Prof. Mike Chan’s journey began in Europe, where he spent nearly four decades in Switzerland and Germany, training under some of the most demanding scientific environments in biomedical research. At a time when stem cell science was viewed with scepticism, he immersed himself in cellular biology, mitochondrial medicine, immunology, and organ regeneration—often operating years ahead of regulatory comfort and mainstream acceptance.
Over the course of his career, Prof. Mike Chan has authored more than 60 medical books and over 140 scientific publications, and founded the world’s first international stem cell association, helping establish early global standards for safety, ethics, and clinical discipline in regenerative medicine.
In 2025, Genesis Scientific Publications formally recognized Prof. Mike Chan’s scholarly excellence by naming him “The Best Author of 2025”, citing his exceptional contributions across four peer-reviewed journals spanning regenerative medicine, stem cell research, and longevity science—including publications on mitochondrial peptides and cell extracts in regenerative medicine, mapping human organ aging for precision medicine applications, innovative approaches to Alzheimer’s disease management, and emerging anabolic peptides in athletic body recomposition. The recognition followed the publication of his collaborative paper “Peptide Therapy in Animal Reproductive Health: Advances, Mechanisms, and Translational Perspectives” in the Journal of Stem Cell Research, co-authored with an international team from Heidelberg University, UC Irvine, and Malaysian institutions. This award underscores not only the volume and consistency of his research output, but the breadth of his translational work—moving decisively from laboratory validation across multiple biomedical domains into real-world clinical and performance applications.
Yet Prof. Mike Chan has never regarded science as an academic exercise alone.
“Research must serve patients,” he has often said. “Otherwise, it is incomplete.”
Precision, Not Promises
What distinguishes Prof. Mike Chan in an increasingly crowded longevity marketplace is his unwavering insistence on precision medicine. He has long rejected the commercialised idea that a single stem cell type can be used as a universal solution—a shortcut now common in poorly regulated wellness markets.
Instead, his work focuses on organ-specific and brain-specific precursor cellular therapy, pairing the correct biological cell with the exact tissue or neural region in decline. Alzheimer’s disease, Parkinson’s disease, autism spectrum disorders, autoimmune degeneration, endocrine collapse—each, he argues, speaks a different cellular language.
“You don’t give one answer to every question,” Prof. Mike Chan told delegates at the We Are The World Global Summit in Bangkok. “Biology doesn’t work that way.”
That position has earned him rare public validation from senior figures in longevity and regenerative medicine.
Dr. Claude Chauchard, founder of the European Academy for Preventive Medicine, described Prof. Mike Chan’s approach as “a return to biological truth in an era overwhelmed by shortcuts,” noting that “precision is not innovation theatre — it is the only path that will survive regulatory and clinical scrutiny.”
Dr. Michael Yeo, a senior regulatory scientist (ret.) with the U.S. Food and Drug Administration (FDA), said he was introduced for the first time to Prof. Mike Chan’s mitochondrial-oriented therapy (MO) at the longevity forum, describing it as a new way of thinking about aging at the cellular energy level.
He noted that while longevity medicine challenges existing regulatory models, Prof. Mike Chan’s mitochondrial focus offered a potentially meaningful biological framework for future longevity research and evaluation.
Prof. Zhongchao Han, a globally recognised authority in cellular and translational medicine, observed that “many institutions are still debating precision regenerative medicine as a concept, while Prof. Mike Chan has already operationalized it across continents.”
Collectively, these endorsements position Prof. Mike Chan not merely as a practitioner, but as a reference point for how regenerative medicine should be responsibly practised.
THE LONGEVITY EQUATION
Prof. Mike Chan defines longevity as a biological sequence, not a single outcome. Stem cell vitality underpins brain resilience.
He said: “I always say that healthspan depends on brainspan, and that depends on your stemcell”
Ultimately brain resilience sustains organ function and overall healthspan. When this order is preserved, quality of life can be extended meaningfully over time.
For Prof. Mike Chan, longevity is not about adding years—it is about extending function.
He frames aging as a biological process driven by organ deterioration, not by the calendar alone. The lungs begin declining as early as the 20s. The heart shows functional stress by the 40s. The pancreas weakens in the mid-50s. Cognitive decline accelerates after 65. Meanwhile, endogenous stem cell reserves fall to roughly five percent by age 60.
His response is not conjecture, but strategy: restore organ integrity, protect the brain, and rebuild cellular reserves.
Notably, Prof. Mike Chan speaks openly about his own data. At age 64, his biological age measured 46, reflecting an 18-year reversal sustained under monitored, evidence-based protocols.
“Living to 120 means nothing if you lose your mind at 75,” he told the audience in Bangkok. “Longevity without clarity is not success.”
This philosophy is now underpinned by one of his most consequential scientific contributions: the Human Cytology Atlas, authored in 2025 and published with Genesis Biomedical Research Institute. Mapping more than 400 distinct human cell types, the Atlas provides the biological blueprint behind Prof. Mike Chan’s long-held principle that “A1 must treat A1.”
In practical terms, the Atlas explains why generic stem cell injections often fail: the liver is not the brain; the brain is not the pancreas; and cells are not interchangeable.
A Global Humanitarian, Not Just a Scientist
Behind the clinical rigor lies a deeply personal ethic. Prof. Mike Chan has treated patients across more than 40 international medical centers, many of them late-stage or previously labelled “untreatable.” He has trained paediatric doctors in Baoding, China, for autism diagnosis and gut–brain intervention, and has consistently advocated for increased global investment in Alzheimer’s and Parkinson’s research.
“I am a businessman,” he says plainly. “But with a conscience.”
His work extends firmly into government and state-level collaboration. Prof. Mike Chan has participated in WHO-linked scientific exchanges since 2007 and has worked directly with the German government, including engagements in Cologne involving senior German officials. Since 2018, he has served as a Senator of the German Federal Association for Economic Development and Foreign Trade (BWA), fostering cross-border biomedical collaboration between Germany and Asia—an appointment that underscores his standing at the intersection of science, policy, and economic diplomacy.
He has collaborated with the Chinese government and Brunei’s Health Ministry on national wellness initiatives. He also works with Jerudong Park Medical Center (JPMC)—Brunei’s most prestigious medical institution and healthcare provider for the royal family—as well as Caribbean governments, including Antigua and the Bahamas, on longevity frameworks.
Symbolically, Prof. Mike Chan’s contributions have been commemorated through official national portrait stamp collections released in 2023 and again in 2025—an honour typically reserved for heads of state, cultural icons, and historic figures, underscoring his role as a scientific bridge between East and West.
Asia as the Next Frontier
While Prof. Mike Chan’s scientific roots lie in Europe, his outlook is unequivocal.
“Asia is where the momentum is,” he told international media. “Not just purchasing power — but openness to prevention, integrative medicine, and long-term thinking.”
At the We Are The World Global Summit 2025, his sessions drew full-room audiences and generated over 100 Chinese media features, reaching more than 300 million viewers in China alone. China Daily Global added an estimated 450 million international impressions, with global broadcaster TVB-1 extending reach toward half a billion.
“It was not just a summit. It was a signal.”
Beyond Bangkok, Prof. Mike Chan’s influence in East Asia has further expanded through Japan, where he serves as Chairman of MMJ (Multi-Dimensional Holistic Medical Team Japan, strengthening cross-border medical leadership and regional collaboration.
At the recent American Academy of Anti-Aging Medicine’s (A4M) Longevity Fest 2025 in Las Vegas from December 12th to 14th, Prof. Mike Chan delivered a featured presentation on stem-cell regeneration and precision regenerative medicine that commanded a full house of attendees, establishing himself as the only Malaysian speaker at the three-day congress. As he came down from the stage following his final session, delegates surged toward him, gathering around to network and seek a deeper understanding of his translational regenerative protocols—a sustained engagement that extended well beyond the lecture hall and onto the exhibition floor. This dual presence, both scientific authority and accessible practitioner educator, reinforced EWBG’s positioning at the convergence of academic research and real-world clinical delivery in the global longevity movement.
Prof Chan’s appointment as a Senator of the German Federal Association for Economic Development and Foreign Trade (BWA) since 2018 plays a crucial role in fostering economic development and foreign trade relations between Germany and key Asian nations. This government-led appointment underscores his international recognition and influence in the field ofprogenitorstem cell research and regenerative medicine in driving cross-border innovations.
His engagement in China as BWA Senator and under the invitation of the Chinese Government continues to deepen through collaborations with Beijing Children’s Hospital in Baoding, where a 1,000-bed hospital was built under government collaboration, and he has trained more than a thousand paediatric doctors in Hebei and Baoding, China, across two separate large-scale medical lectures.
Aside from that, Prof. Mike Chan’s repeated features in China’s Foreign Trade Magazine have positioned him as one of the most visible foreign voices in China’s longevity dialogue.
Performance Medicine and Sabah FC
Prof. Mike Chan’s regenerative philosophy does not stop at aging populations. In late 2025, European Wellness formalized a biomedical partnership with Sabah Football Club, applying the same principles of precision diagnostics, cellular recovery, and organ optimization to elite athletes.
The collaboration focuses on injury prevention, accelerated recovery, stamina, and career longevity, recognizing that professional athletes experience biological aging at an accelerated rate.
“Athletes don’t retire because they lose skill,” Prof. Mike Chan explains. “They retire because recovery fails. When you manage recovery at the cellular level, performance extends naturally.”
The Sabah FC partnership marks European Wellness’ growing role in sports science and performance medicine, translating longevity science into competitive advantage.
Prof. Mike Chan in World News
Selected International Coverage & Resources
Prof. Dato’ Sri Dr. Mike Chan’s work in precision regenerative medicine, longevity science, and cellular therapy has received sustained coverage across global financial media, scientific platforms, international summits, and healthcare publications. Selected international features include:
- Global Spotlight on Autism: Prof. Mike Chan Responds to Trump’s Speech with a Call for Precision Medicine European Wellness (International)
https://european-wellness.eu/events/global-spotlight-on-autism/ - Beyond Immortality: Why the Future of Longevity Lies in Cells, Not Organs
| European Wellness / Global Health Commentary
https://european-wellness.eu/events/future-longevity-lies-in-cells/
Video explainer: https://www.youtube.com/watch?v=DhF0HSLMTGE - The Real Jerry Maguire Meets Prof. Mike Chan to Discuss Sports Injuries and Concussion Recovery | Yahoo Finance (U.S. / Global Business Media)
https://finance.yahoo.com/news/real-jerry-maguire-meets-prof-180200926.html
Video interview: https://www.youtube.com/watch?v=Yi53FHEGQMY - Mapping the Code of Life: 400+ Human Cell Types in a Landmark Cytology Atlas| Yahoo Finance – Science & Innovation
https://finance.yahoo.com/news/mapping-code-life-european-wellness-162600815.html
Video explainer: https://www.youtube.com/watch?v=i7Gtmn1PqBQ - Breaking Barriers in Autism: Bioregenerative Breakthroughs with Prof. Mike Chan|Yahoo Finance UK / International Health
https://uk.finance.yahoo.com/news/breaking-barriers-autism-european-wellness-201700225.html
Video coverage: https://www.youtube.com/watch?v=KkMvj3Rr0kg&t=2s - European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan |Business Insider / Markets Insider (Global Finance & Science)
https://markets.businessinsider.com/news/stocks/european-wellness-biomedical-group-announces-new-klotho-research-initiative-led-by-prof.-mike-chan-1034162991
- Comprehensive Guide on Animal Stem Cell Therapy Released by European Wellness| Business Insider / Markets Insider
https://markets.businessinsider.com/news/stocks/european-wellness-biomedical-group-releases-comprehensive-guide-on-animal-stem-cell-therapy-1034147794 - Bioregenerative Blueprint for Athletic Longevity Released by Prof. Mike Chan
| Business Insider / Global Sports & Health Science
https://markets.businessinsider.com/news/stocks/european-wellness-biomedical-group-headed-by-prof.-mike-chan-release-new-study-on-bioregenerative-blueprint-for-athletic-longevity-1034067908
These articles and explainer videos collectively document Prof. Mike Chan’s role as both scientific authority and global thought leader.
Redefining the Future of Medicine
As medicine confronts aging populations, chronic disease, and unsustainable healthcare costs, Prof. Mike Chan offers a reframing that is both radical and grounded: treat the root, not the symptom; restore systems, not silence alarms.
“We cannot stop aging,” he says. “But we can slow decline, reverse biological damage, and protect the mind.”
As he reflects on his journey, Prof. Mike Chan acknowledges the unwavering support behind the work: “The support of my beloved wife, Professor Dato’ Sri Dr. Michelle Wong, and my family, who believed in me and stood by me throughout this journey. Together, we will turn hopes into reality—especially for the untreatable.”
And in that quiet confidence lies his enduring legacy: a future where aging is no longer feared—but understood, managed, and, increasingly, rewritten.